Product Images Tremfya
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 31 images provide visual information about the product associated with Tremfya NDC 57894-640 by Janssen Biotech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - tremfya 01
The text above shows a graph with the percentages of subjects in a clinical trial over time. The trial compared a placebo treatment with Guselkumab administered every 8 weeks at a dose of 100mg. The X-axis of the graph represents the weeks of the trial, while the Y-axis depicts the percentage of subjects in each treatment group.*
tremfya 01a
Figure - tremfya 02
Figure - tremfya 03
This is a warning label for a medical syringe. The plunger should not be held or pulled at any time, and the syringe body should be held below the finger flange for safe injection. The needle cover should not be removed until ready to use.*
Figure - tremfya 04
Plungerlocks are a type of locking mechanism that features a safety guard with seven activations. This mechanism also includes a retractable needle that moves into the body for added safety.*
Figure - tremfya 05
Figure - tremfya 06
Figure - tremfya 07
Figure - tremfya 08
Figure - tremfya 09
Figure - tremfya 10
Figure - tremfya 11
Figure - tremfya 12
Figure - tremfya 13
Figure - tremfya 14
Figure - tremfya 15
Figure - tremfya 16
PRINCIPAL DISPLAY PANEL - 100 mg/mL Syringe Carton - tremfya 17
tremfya 18
This text describes the physical components of an object, including a handle, a teal body, a window, a needle guard, and a bottom cap. The context of the object is not specified, so further information is required to understand its purpose.*
tremfya 19
tremfya 20
tremfya 21
tremfya 22
tremfya 23
tremfya 24
tremfya 25
tremfya 26
tremfya 27
tremfya 28
tremfya 29
tremfya 30
This is a medication label for the drug Tremfya (qsulukumab), which is an injection for subcutaneous use only. It contains no preservatives and comes in a single-dose one-press patient-controlled injector with a strength of 100mg/mL. The label provides a NDC product code and a warning to dispense the enclosed medication guide to each patient. The rest of the text is not related to the medication and appears to be random letters and numbers which cannot be interpreted.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.